Although discussing IDH detection through radiomics is beyond the scope of our work, it is worth mentioning that radiogenomics has represented a useful tool to forecast and classify patients with low-grade and high-grade gliomas according to risk groups, thanks to the evaluation of IDH mutation, along with 1p19q codeletion. Here, IDH1 is linked to central nervous system cancer.